Subjects: H.R.949 — 109th Congress (2005-2006)

  • Access to health care
  • Centers for Disease Control and Prevention (CDC)
  • Clinical trials
  • Communication in medicine
  • Congress
  • Congressional reporting requirements
  • Department of Health and Human Services
  • Drug approvals
  • Education
  • Executive reorganization
  • Food and Drug Administration (FDA)
  • Government Operations and Politics
  • Government publicity
  • Health
  • Health education
  • Health information systems
  • Health planning
  • Higher education
  • Medical education
  • Medical ethics
  • Medical research
  • Medical supplies
  • Pharmaceutical research
  • Preventive medicine
  • Quality of care
  • Science, Technology, Communications
  • Women
  • Women's health